M Evo Gbl Acquisition Corp Ii has 5 Schedule 13D or 13G filings on record since 2026-02-03. 3 holders' latest filing reports 5% or more of class a ordinary shares, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Evolution Sponsor Holdings LLC Ii | 25% | 10,000,000 | SCHEDULE 13D, 2026-02-03 | 2026-02-03 |
| Adage Capital Management, L.P. | 8.1% | 2,430,000 | SCHEDULE 13G, 2026-05-13 | 2026-03-31 |
| Aristeia Capital, L.L.C. | 6.11% | 1,833,442 | SCHEDULE 13G, 2026-05-14 | 2026-03-31 |
| The Goldman Sachs Group, Inc. | 1.7% | 502,491 | SCHEDULE 13G/A, 2026-08-14 | 2026-06-30 |
Purpose of Transaction (Item 4)
Evolution Sponsor Holdings LLC Ii
Founder Shares In connection with the organization of the Issuer, on August 22, 2025, our sponsor paid $25,000, or approximately $0.003 per share, to cover certain of our offering costs in exchange for 8,333,333 founder shares. On January 29, 2026, the Company issued 1,666,667 Class B ordinary shares to the sponsor in a share capitalization, resulting in the total Class B ordinary shares increasing to 10,000,000 Class B ordinary shares, in connection with the Issuer's initial public offering ("IPO"), which was declared effective on January 29, 2026. See Issuer's registration statement on Form S-1 (File No. 333- 292138 and 333-293064, the "Registration Statements"), under the heading "Certain Transactions." Public Units On February 2, 2026, the Company closed its initial public offering of 30,000,000 units, at a price of $10.00 per unit (the "Public Units"), for an aggregate purchase price of $300,000,000 with the exercise of the Over-Allotment Option in connection with the Issuer's IPO for an aggregate of $300,000,000. Each Public Unit consists of one ordinary share and one-half warrant (each, a "warrant"). Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share (as described more fully in the Registration Statement). Private Placement Warrants On February 2, 2026, simultaneously with the closing of the Issuer's IPO, the Sponsor, Cohen and Company Capital Markets, a division of Cohen & Company Securities, LLC …The first part of Item 4 of the SCHEDULE 13D filed 2026-02-03; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-02-03 | Evolution Sponsor Holdings LLC Ii | 25% | SCHEDULE 13D |
| 2026-05-11 | The Goldman Sachs Group, Inc. | 5.1% | SCHEDULE 13G |
| 2026-05-13 | Adage Capital Management, L.P. | 8.1% | SCHEDULE 13G |
| 2026-05-14 | Aristeia Capital, L.L.C. | 6.11% | SCHEDULE 13G |
| 2026-08-14 | The Goldman Sachs Group, Inc. | 1.7% | SCHEDULE 13G/A |
Tools for this story
Each opens in a new tab, filled in for M Evo Gbl Acquisition Corp Ii. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.